Atlas Trials

Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer

Clinical trial NCT03050060 · TERMINATED

Trial details

NCT number
NCT03050060
Sponsor
University of Washington
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Kidney CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage IV Cutaneous Melanoma AJCC v6 and v7Stage IV Renal Cell Cancer AJCC v7Stage IV Lung Non-Small Cell Cancer AJCC v7
Start date
2017-06-09
Primary completion
2018-10-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.